Redmile Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12M | Hold |
2,074,350
| – | – | 0.55% | 33 |
|
|
2025
Q1 | $4.13M | Hold |
2,074,350
| – | – | 0.39% | 40 |
|
|
2024
Q4 | $6.06M | Hold |
2,074,350
| – | – | 0.42% | 44 |
|
|
2024
Q3 | $8.03M | Hold |
2,074,350
| – | – | 0.47% | 40 |
|
|
2024
Q2 | $10.7M | Hold |
2,074,350
| – | – | 0.64% | 38 |
|
|
2024
Q1 | $14.5M | Buy |
2,074,350
+750,000
| +57% | +$5.25M | 0.53% | 48 |
|
|
2023
Q4 | $11.7M | Hold |
1,324,350
| – | – | 0.42% | 49 |
|
|
2023
Q3 | $12.6M | Hold |
1,324,350
| – | – | 0.6% | 40 |
|
|
2023
Q2 | $19.4M | Sell |
1,324,350
-668,493
| -34% | -$9.79M | 0.74% | 40 |
|
|
2023
Q1 | $24.5M | Sell |
1,992,843
-216,507
| -10% | -$2.66M | 1.06% | 37 |
|
|
2022
Q4 | $41M | Buy |
+2,209,350
| New | +$41M | 1.68% | 21 |
|